Cargando…
Preservation of renal function in cardiac surgery patients with low cardiac output syndrome: levosimendan vs beta agonists
BACKGROUND: Some studies have been performed to assess the effects of levosimendan on cardiac function when administered to cardiac surgery patients with low cardiac output syndrome (LCOS) in the immediate postoperative period. Levosimendan is an inotropic agent for the treatment of low cardiac outp...
Autores principales: | Guerrero Orriach, Jose Luis, Navarro Arce, I., Hernandez Rodriguez, P., Raigón Ponferrada, A., Malo Manso, A., Ramirez Aliaga, M., Ramirez Fernandez, A., Escalona Belmonte, J. J., Bellido Estevez, I., Gomez Luque, A., Barrera Serrano, R., Toledo Medina, C. S., Rubio Navarro, M., Cruz Mañas, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6859602/ https://www.ncbi.nlm.nih.gov/pubmed/31735161 http://dx.doi.org/10.1186/s12871-019-0888-2 |
Ejemplares similares
-
Renal and Neurologic Benefit of Levosimendan vs Dobutamine in Patients With Low Cardiac Output Syndrome After Cardiac Surgery: Clinical Trial FIM-BGC-2014-01
por: Guerrero-Orriach, Jose L., et al.
Publicado: (2020) -
Cardioprotection with halogenated gases: how does it occur?
por: Guerrero-Orriach, Jose Luis, et al.
Publicado: (2017) -
Beneficial Effects of Halogenated Anesthetics in Cardiomyocytes: The Role of Mitochondria
por: Guerrero-Orriach, José Luis, et al.
Publicado: (2023) -
Cardiac, renal, and neurological benefits of preoperative levosimendan administration in patients with right ventricular dysfunction and pulmonary hypertension undergoing cardiac surgery: evaluation with two biomarkers neutrophil gelatinase-associated lipocalin and neuronal enolase
por: Guerrero-Orriach, José Luis, et al.
Publicado: (2016) -
Anaesthesia and cancer: can anaesthetic drugs modify gene expression?
por: Ponferrada, Aida Raigon, et al.
Publicado: (2020)